Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Antistaphylococcal activity of oritavancin and its synergistic effect in combination with other antimicrobial agents.

Lin G, Pankuch G, Appelbaum PC, Kosowska-Shick K.

Antimicrob Agents Chemother. 2014 Oct;58(10):6251-4. doi: 10.1128/AAC.02932-14. Epub 2014 Jul 14.

2.

Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill.

Lin G, Pankuch GA, Appelbaum PC, Kosowska-Shick K.

Diagn Microbiol Infect Dis. 2012 Jul;73(3):287-9. doi: 10.1016/j.diagmicrobio.2012.04.003. Epub 2012 May 8.

PMID:
22575272
3.

Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.

Mendes RE, Tsakris A, Sader HS, Jones RN, Biek D, McGhee P, Appelbaum PC, Kosowska-Shick K.

J Antimicrob Chemother. 2012 Jun;67(6):1321-4. doi: 10.1093/jac/dks069. Epub 2012 Mar 7.

PMID:
22398650
4.

Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.

Clark C, McGhee P, Appelbaum PC, Kosowska-Shick K.

Antimicrob Agents Chemother. 2011 May;55(5):2344-51. doi: 10.1128/AAC.01602-10. Epub 2011 Feb 22.

5.

In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.

McGhee P, Clark C, Credito K, Beachel L, Pankuch GA, Appelbaum PC, Kosowska-Shick K.

Antimicrob Agents Chemother. 2011 May;55(5):2417-9. doi: 10.1128/AAC.01672-10. Epub 2011 Feb 22.

6.

Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa.

Pankuch GA, Lin G, Kubo A, Armstrong ES, Appelbaum PC, Kosowska-Shick K.

Antimicrob Agents Chemother. 2011 May;55(5):2463-5. doi: 10.1128/AAC.01390-10. Epub 2011 Jan 31.

7.

Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.

Lemaire S, Kosowska-Shick K, Appelbaum PC, Glupczynski Y, Van Bambeke F, Tulkens PM.

J Antimicrob Chemother. 2011 Mar;66(3):596-607. doi: 10.1093/jac/dkq478. Epub 2010 Dec 23.

PMID:
21186193
8.

Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.

Kosowska-Shick K, Julian KG, McGhee PL, Appelbaum PC, Whitener CJ.

Diagn Microbiol Infect Dis. 2010 Sep;68(1):34-9. doi: 10.1016/j.diagmicrobio.2010.05.007.

PMID:
20727467
9.

Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.

Lemaire S, Kosowska-Shick K, Appelbaum PC, Verween G, Tulkens PM, Van Bambeke F.

Antimicrob Agents Chemother. 2010 Jun;54(6):2549-59. doi: 10.1128/AAC.01724-09. Epub 2010 Apr 12.

10.

Mutant prevention concentrations of four carbapenems against gram-negative rods.

Credito K, Kosowska-Shick K, Appelbaum PC.

Antimicrob Agents Chemother. 2010 Jun;54(6):2692-5. doi: 10.1128/AAC.00033-10. Epub 2010 Mar 22.

11.

Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.

Kosowska-Shick K, McGhee PL, Appelbaum PC.

Antimicrob Agents Chemother. 2010 May;54(5):1670-7. doi: 10.1128/AAC.00019-10. Epub 2010 Mar 1.

12.

Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.

Credito K, Kosowska-Shick K, McGhee P, Pankuch GA, Appelbaum PC.

Antimicrob Agents Chemother. 2010 Feb;54(2):673-7. doi: 10.1128/AAC.01353-09. Epub 2009 Dec 14.

13.

In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.

McGhee P, Clark C, Kosowska-Shick KM, Nagai K, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2010 Jan;54(1):230-8. doi: 10.1128/AAC.01123-09. Epub 2009 Nov 2.

14.

Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.

Kosowska-Shick K, Clark C, Pankuch GA, McGhee P, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Oct;53(10):4217-24. doi: 10.1128/AAC.00742-09. Epub 2009 Jul 20.

15.

Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.

Clark C, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Jul;53(7):3118-21. doi: 10.1128/AAC.00183-09. Epub 2009 May 11.

16.

Comparative antipneumococcal activities of sulopenem and other drugs.

Kosowska-Shick K, Ednie LM, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Jun;53(6):2239-47. doi: 10.1128/AAC.01531-08. Epub 2009 Mar 23.

17.

Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.

Kosowska-Shick K, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2009 May;53(5):2176-80. doi: 10.1128/AAC.01566-08. Epub 2009 Feb 23.

18.

Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.

Clark C, Ednie LM, Lin G, Smith K, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Caspers P, Gaucher B, Mert G, Shapiro S, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Apr;53(4):1353-61. doi: 10.1128/AAC.01619-08. Epub 2009 Feb 2.

19.

In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.

Bhagwat SS, McGhee P, Kosowska-Shick K, Patel MV, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Feb;53(2):811-3. doi: 10.1128/AAC.01150-08. Epub 2008 Nov 24. Erratum in: Antimicrob Agents Chemother. 2009 Mar;53(3):1298.

20.

Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.

Kosowska-Shick K, Ednie LM, McGhee P, Smith K, Todd CD, Wehler A, Appelbaum PC.

Antimicrob Agents Chemother. 2008 Dec;52(12):4510-3. doi: 10.1128/AAC.01073-08. Epub 2008 Oct 6.

21.

Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.

Lemaire S, Kosowska-Shick K, Julian K, Tulkens PM, Van Bambeke F, Appelbaum PC.

Clin Microbiol Infect. 2008 Aug;14(8):766-77. doi: 10.1111/j.1469-0691.2008.02035.x.

22.

Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureus strains.

Sabat AJ, Wladyka B, Kosowska-Shick K, Grundmann H, van Dijl JM, Kowal J, Appelbaum PC, Dubin A, Hryniewicz W.

BMC Microbiol. 2008 Jul 29;8:129. doi: 10.1186/1471-2180-8-129.

23.

In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzae.

Kosowska-Shick K, Clark C, Credito K, Dewasse B, Beachel L, Ednie L, Appelbaum PC.

Antimicrob Agents Chemother. 2008 Feb;52(2):748-52. Epub 2007 Dec 17.

24.

Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.

Ikenaga M, Kosowska-Shick K, Gotoh K, Hidaka H, Koga H, Masunaga K, Nagai K, Tsumura N, Appelbaum PC, Matsuishi T.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):16-22. Epub 2007 Dec 18.

PMID:
18068325
25.

Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.

Clark CL, Kosowska-Shick K, Ednie LM, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Nov;51(11):4196-201. Epub 2007 Sep 17.

26.

Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.

Bogdanovich T, Clark C, Kosowska-Shick K, Dewasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Nov;51(11):4191-5. Epub 2007 Sep 17.

27.

Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.

Julian K, Kosowska-Shick K, Whitener C, Roos M, Labischinski H, Rubio A, Parent L, Ednie L, Koeth L, Bogdanovich T, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Sep;51(9):3445-8. Epub 2007 Jul 9.

28.

Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.

Kosowska-Shick K, Credito KL, Pankuch GA, DeWasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Feb;51(2):770-3. Epub 2006 Nov 20.

29.

Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis.

Kosowska-Shick K, Smith K, Bogdanovich T, Ednie LM, Jones RN, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Dec;50(12):4191-4. Epub 2006 Oct 16.

30.

Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre study.

Stratchounski LS, Kozlov RS, Appelbaum PC, Kretchikova OI, Kosowska-Shick K.

Clin Microbiol Infect. 2006 Sep;12(9):853-66.

31.

Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.

Kosowska-Shick K, Credito K, Pankuch GA, Lin G, Bozdogan B, McGhee P, Dewasse B, Choi DR, Ryu JM, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Jun;50(6):2064-71.

32.

Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.

Kosowska-Shick K, Clark C, Credito K, McGhee P, Dewasse B, Bogdanovich T, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Feb;50(2):765-9.

33.

Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates.

Malachowa N, Sabat A, Gniadkowski M, Krzyszton-Russjan J, Empel J, Miedzobrodzki J, Kosowska-Shick K, Appelbaum PC, Hryniewicz W.

J Clin Microbiol. 2005 Jul;43(7):3095-100.

Supplemental Content

Loading ...
Support Center